Your browser doesn't support javascript.
Promising Enzymes for Inhibitors Development Against COVID-19.
Sun, Zhi-Gang; Yu, Feng-Ling; Qiu, Xiang-Ting; Li, Shuang; Li, Xue-Tang; Zhu, Hai-Liang.
  • Sun ZG; Central Laboratory, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, China.
  • Yu FL; Pharmacy Department, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, China.
  • Qiu XT; Clinical Laboratory, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, China.
  • Li S; Pharmacy Department, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, China.
  • Li XT; Pharmacy Department, Linyi Central Hospital, No.17 Jiankang Road, Linyi 276400, China.
  • Zhu HL; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No.163 Xianlin Road, Nanjing 210023, China.
Mini Rev Med Chem ; 22(3): 449-456, 2022.
Article in English | MEDLINE | ID: covidwho-1346361
ABSTRACT
After the emergence of COVID-19 in 2019, it has now become a pandemic. COVID-19 has brought painful disasters to people all over the world. It not only threatens lives and health but also induces economic crises. At present, promising methods to eradicate COVID-19 mainly include drugs and vaccines. Enzyme inhibitors have always been a reliable strategy for the treatment of related diseases. Scientists worldwide have worked together to study COVID-19, obtained the structure of key SARS-CoV-2 associated enzymes, and reported the research of inhibitors of these enzymes. This article summarizes COVID-19-related enzyme inhibitors' recent development, mainly including 3CLpro, PLpro, TMPRSS2, and RdRp inhibitors, hoping to provide valuable weapons in the ensuing battle against COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Enzyme Inhibitors / COVID-19 Drug Treatment Topics: Vaccines Limits: Humans Language: English Journal: Mini Rev Med Chem Journal subject: Chemistry Year: 2022 Document Type: Article Affiliation country: 1389557521666210805104250

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Enzyme Inhibitors / COVID-19 Drug Treatment Topics: Vaccines Limits: Humans Language: English Journal: Mini Rev Med Chem Journal subject: Chemistry Year: 2022 Document Type: Article Affiliation country: 1389557521666210805104250